There is a breast cancer vaccine in development. It has been used in mice and they hope to start human clinical trials in the next year.
This vaccine is being developed by an immunologist named Vincent Tuohy. It would be given to women in their 40's, since it would detroy healthy tissue if the women were to lactate. The vaccine seeks out alpha-lactalbumin (a protein found in many breast cancers and in lactating breast tissue, but not non-lactating tissue).
Breast cancer affects so many Canadian women every year. It is scary, the treatments are invasive, and many women don't survive. If a vaccine can help save more lives, I'm all for it. But...
With so many looming questions about the long-term safety of vaccines I have some doubts. Guardisil was supposed to save many young women from cervical cancer by creating immunity to HPV strains. There are still a lot of questions about it's safety.
Western medicine is not know for it's patience. I know that women with high risk for breast cancer and reasearchers want these vaccines on the market ASAP, and I understand their point of view. However, what I would like to see is these clinical trials go for 20 years - follow these women and see what happens to them. Are they really healthier for having it or do they develop other conditions in a higher percentage than the rest of the population? Do these women start to develop other cancers? Once we know for sure that these women really are better off to have had the vaccine, then I say put it on the market and let's go. But without these answers, it's just another shot in the dark.
Yours in Health,
Kerri Fullerton ND